Cargando...
Development of Therapeutic Vaccines for Ovarian Cancer
Ovarian cancer remains the deadliest of all gynecologic malignancies. Our expanding knowledge of ovarian cancer immunology has allowed the development of therapies that generate systemic anti-tumor immune responses. Current immunotherapeutic strategies include immune checkpoint blockade, cellular th...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
MDPI AG
2020-11-01
|
Colección: | Vaccines |
Materias: | |
Acceso en línea: | https://www.mdpi.com/2076-393X/8/4/657 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|